List of Tables
Table 1. Global Cyclic Peptides Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cyclic Peptides Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cyclic Peptides Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cyclic Peptides Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cyclic Peptides Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Cyclic Peptides Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 7. Global Cyclic Peptides Sales by Region (2020-2025) & (kg)
Table 8. Global Cyclic Peptides Sales by Region (2026-2031) & (kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Cyclic Peptides Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 11. Global Cyclic Peptides Production by Region (2020-2025) & (kg)
Table 12. Global Cyclic Peptides Production by Region (2026-2031) & (kg)
Table 13. Global Cyclic Peptides Sales by Manufacturers (2020-2025) & (kg)
Table 14. Global Cyclic Peptides Sales Share by Manufacturers (2020-2025)
Table 15. Global Cyclic Peptides Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Cyclic Peptides Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Cyclic Peptides by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclic Peptides as of 2024)
Table 19. Global Cyclic Peptides Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Cyclic Peptides Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)
Table 21. Key Manufacturers Cyclic Peptides Manufacturing Base and Headquarters
Table 22. Global Cyclic Peptides Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Cyclic Peptides Sales by Type (2020-2025) & (kg)
Table 26. Global Cyclic Peptides Sales by Type (2026-2031) & (kg)
Table 27. Global Cyclic Peptides Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Cyclic Peptides Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Cyclic Peptides ASP by Type (2020-2031) & (US$/g)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Cyclic Peptides Sales by Application (2020-2025) & (kg)
Table 32. Global Cyclic Peptides Sales by Application (2026-2031) & (kg)
Table 33. Cyclic Peptides High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Cyclic Peptides Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Cyclic Peptides Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Cyclic Peptides ASP by Application (2020-2031) & (US$/g)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Cyclic Peptides Growth Accelerators and Market Barriers
Table 40. North America Cyclic Peptides Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Cyclic Peptides Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Cyclic Peptides Growth Accelerators and Market Barriers
Table 43. Europe Cyclic Peptides Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Cyclic Peptides Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Cyclic Peptides Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Cyclic Peptides Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Cyclic Peptides Growth Accelerators and Market Barriers
Table 48. Southeast Asia Cyclic Peptides Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Cyclic Peptides Investment Opportunities and Key Challenges
Table 50. Central and South America Cyclic Peptides Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Cyclic Peptides Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Cyclic Peptides Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. JPT Peptide Technologies GmbH Corporation Information
Table 54. JPT Peptide Technologies GmbH Description and Major Businesses
Table 55. JPT Peptide Technologies GmbH Product Models, Descriptions and Specifications
Table 56. JPT Peptide Technologies GmbH Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 57. JPT Peptide Technologies GmbH Sales Value Proportion by Product in 2024
Table 58. JPT Peptide Technologies GmbH Sales Value Proportion by Application in 2024
Table 59. JPT Peptide Technologies GmbH Sales Value Proportion by Geographic Area in 2024
Table 60. JPT Peptide Technologies GmbH Cyclic Peptides SWOT Analysis
Table 61. JPT Peptide Technologies GmbH Recent Developments
Table 62. BACHEM Corporation Information
Table 63. BACHEM Description and Major Businesses
Table 64. BACHEM Product Models, Descriptions and Specifications
Table 65. BACHEM Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 66. BACHEM Sales Value Proportion by Product in 2024
Table 67. BACHEM Sales Value Proportion by Application in 2024
Table 68. BACHEM Sales Value Proportion by Geographic Area in 2024
Table 69. BACHEM Cyclic Peptides SWOT Analysis
Table 70. BACHEM Recent Developments
Table 71. CPC Scientific Corporation Information
Table 72. CPC Scientific Description and Major Businesses
Table 73. CPC Scientific Product Models, Descriptions and Specifications
Table 74. CPC Scientific Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. CPC Scientific Sales Value Proportion by Product in 2024
Table 76. CPC Scientific Sales Value Proportion by Application in 2024
Table 77. CPC Scientific Sales Value Proportion by Geographic Area in 2024
Table 78. CPC Scientific Cyclic Peptides SWOT Analysis
Table 79. CPC Scientific Recent Developments
Table 80. Pepscan Corporation Information
Table 81. Pepscan Description and Major Businesses
Table 82. Pepscan Product Models, Descriptions and Specifications
Table 83. Pepscan Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 84. Pepscan Sales Value Proportion by Product in 2024
Table 85. Pepscan Sales Value Proportion by Application in 2024
Table 86. Pepscan Sales Value Proportion by Geographic Area in 2024
Table 87. Pepscan Cyclic Peptides SWOT Analysis
Table 88. Pepscan Recent Developments
Table 89. United States Biological Corporation Information
Table 90. United States Biological Description and Major Businesses
Table 91. United States Biological Product Models, Descriptions and Specifications
Table 92. United States Biological Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. United States Biological Sales Value Proportion by Product in 2024
Table 94. United States Biological Sales Value Proportion by Application in 2024
Table 95. United States Biological Sales Value Proportion by Geographic Area in 2024
Table 96. United States Biological Cyclic Peptides SWOT Analysis
Table 97. United States Biological Recent Developments
Table 98. RS Synthesis Corporation Information
Table 99. RS Synthesis Description and Major Businesses
Table 100. RS Synthesis Product Models, Descriptions and Specifications
Table 101. RS Synthesis Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 102. RS Synthesis Recent Developments
Table 103. Charnwood Discovery Corporation Information
Table 104. Charnwood Discovery Description and Major Businesses
Table 105. Charnwood Discovery Product Models, Descriptions and Specifications
Table 106. Charnwood Discovery Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 107. Charnwood Discovery Recent Developments
Table 108. Bio-Synthesis Corporation Information
Table 109. Bio-Synthesis Description and Major Businesses
Table 110. Bio-Synthesis Product Models, Descriptions and Specifications
Table 111. Bio-Synthesis Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 112. Bio-Synthesis Recent Developments
Table 113. WuXi STA Corporation Information
Table 114. WuXi STA Description and Major Businesses
Table 115. WuXi STA Product Models, Descriptions and Specifications
Table 116. WuXi STA Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 117. WuXi STA Recent Developments
Table 118. GL Biochem(Shanghai) Ltd Corporation Information
Table 119. GL Biochem(Shanghai) Ltd Description and Major Businesses
Table 120. GL Biochem(Shanghai) Ltd Product Models, Descriptions and Specifications
Table 121. GL Biochem(Shanghai) Ltd Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 122. GL Biochem(Shanghai) Ltd Recent Developments
Table 123. Genscript Corporation Information
Table 124. Genscript Description and Major Businesses
Table 125. Genscript Product Models, Descriptions and Specifications
Table 126. Genscript Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 127. Genscript Recent Developments
Table 128. Motif Biotech Corporation Information
Table 129. Motif Biotech Description and Major Businesses
Table 130. Motif Biotech Product Models, Descriptions and Specifications
Table 131. Motif Biotech Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 132. Motif Biotech Recent Developments
Table 133. QYAOBIO Corporation Information
Table 134. QYAOBIO Description and Major Businesses
Table 135. QYAOBIO Product Models, Descriptions and Specifications
Table 136. QYAOBIO Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 137. QYAOBIO Recent Developments
Table 138. Novopro Corporation Information
Table 139. Novopro Description and Major Businesses
Table 140. Novopro Product Models, Descriptions and Specifications
Table 141. Novopro Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 142. Novopro Recent Developments
Table 143. Suzhou Motif Biotechnology Corporation Information
Table 144. Suzhou Motif Biotechnology Description and Major Businesses
Table 145. Suzhou Motif Biotechnology Product Models, Descriptions and Specifications
Table 146. Suzhou Motif Biotechnology Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 147. Suzhou Motif Biotechnology Recent Developments
Table 148. Key Raw Materials Distribution
Table 149. Raw Materials Key Suppliers
Table 150. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 151. Milestones in Production Technology Evolution
Table 152. Distributors List
Table 153. Market Trends and Market Evolution
Table 154. Market Drivers and Opportunities
Table 155. Market Challenges, Risks, and Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyclic Peptides Product Picture
Figure 2. Global Cyclic Peptides Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Disulfide Bond Ring Product Picture
Figure 4. Amide Ring Product Picture
Figure 5. Other Product Picture
Figure 6. Global Cyclic Peptides Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Pharmaceuticals
Figure 8. Scientific Research
Figure 9. Cyclic Peptides Report Years Considered
Figure 10. Global Cyclic Peptides Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 12. Global Cyclic Peptides Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Cyclic Peptides Revenue Market Share by Region (2020-2031)
Figure 14. Global Cyclic Peptides Sales (2020-2031) & (kg)
Figure 15. Global Cyclic Peptides Sales (CAGR) by Region (2020-2031) (kg)
Figure 16. Global Cyclic Peptides Sales Market Share by Region (2020-2031)
Figure 17. Global Cyclic Peptides Capacity, Production and Utilization (2020-2031) & (kg)
Figure 18. Global Cyclic Peptides Production Trend by Region (2020-2031) (kg)
Figure 19. Global Cyclic Peptides Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Cyclic Peptides Production Growth Rate in North America (2020-2031) & (kg)
Figure 22. Cyclic Peptides Production Growth Rate in Europe (2020-2031) & (kg)
Figure 23. Cyclic Peptides Production Growth Rate in China (2020-2031) & (kg)
Figure 24. Cyclic Peptides Production Growth Rate in Japan (2020-2031) & (kg)
Figure 25. Top 5 and Top 10 Manufacturers Cyclic Peptides Sales Volume Market Share in 2024
Figure 26. Global Cyclic Peptides Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Disulfide Bond Ring Revenue Market Share by Manufacturer in 2024
Figure 29. Amide Ring Revenue Market Share by Manufacturer in 2024
Figure 30. Other Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Cyclic Peptides Sales Market Share by Type (2020-2031)
Figure 34. Global Cyclic Peptides Revenue Market Share by Type (2020-2031)
Figure 35. Global Cyclic Peptides Sales Market Share by Application (2020-2031)
Figure 36. Global Cyclic Peptides Revenue Market Share by Application (2020-2031)
Figure 37. North America Cyclic Peptides Sales YoY (2020-2031) & (kg)
Figure 38. North America Cyclic Peptides Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Cyclic Peptides Sales Revenue (US$ Million) in 2024
Figure 40. North America Cyclic Peptides Sales Volume (kg) by Type (2020- 2031)
Figure 41. North America Cyclic Peptides Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Cyclic Peptides Sales Volume (kg) by Application (2020-2031)
Figure 43. North America Cyclic Peptides Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Cyclic Peptides Sales YoY (2020-2031) & (kg)
Figure 48. Europe Cyclic Peptides Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Cyclic Peptides Sales Revenue (US$ Million) in 2024
Figure 50. Europe Cyclic Peptides Sales Volume (kg) by Type (2020-2031)
Figure 51. Europe Cyclic Peptides Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Cyclic Peptides Sales Volume (kg) by Application (2020-2031)
Figure 53. Europe Cyclic Peptides Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 55. France Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Cyclic Peptides Sales YoY (2020-2031) & (kg)
Figure 60. Asia-Pacific Cyclic Peptides Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Cyclic Peptides Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Cyclic Peptides Sales Volume (kg) by Type (2020- 2031)
Figure 63. Asia-Pacific Cyclic Peptides Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Cyclic Peptides Sales Volume (kg) by Application (2020-2031)
Figure 65. Asia-Pacific Cyclic Peptides Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 70. India Cyclic Peptides Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Cyclic Peptides Sales YoY (2020-2031) & (kg)
Figure 72. Central and South America Cyclic Peptides Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Cyclic Peptides Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Cyclic Peptides Sales Volume (kg) by Type (2021-2031)
Figure 75. Central and South America Cyclic Peptides Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Cyclic Peptides Sales Volume (kg) by Application (2020-2031)
Figure 77. Central and South America Cyclic Peptides Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Cyclic Peptides Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Cyclic Peptides Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Cyclic Peptides Sales YoY (2020-2031) & (kg)
Figure 81. Middle East and Africa Cyclic Peptides Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Cyclic Peptides Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Cyclic Peptides Sales Volume (kg) by Type (2021-2031)
Figure 84. South America Cyclic Peptides Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Cyclic Peptides Sales Volume (kg) by Application (2020-2031)
Figure 86. Middle East and Africa Cyclic Peptides Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Cyclic Peptides Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Cyclic Peptides Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Cyclic Peptides Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Cyclic Peptides Revenue (2020-2025) & (US$ Million)
Figure 91. Cyclic Peptides Industry Chain Mapping
Figure 92. Regional Cyclic Peptides Manufacturing Base Distribution (%)
Figure 93. Cyclic Peptides Production Process
Figure 94. Regional Cyclic Peptides Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
